FDA CDER and CBER & Duke-Margolis Center for Health Policy  | Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development - 06/07/2023

The purpose of this public workshop is to discuss topics relevant to the development of endpoints for rare diseases.

Source: FDA Center for Drug Evaluation and Research - What's New - April 17, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news